2013 Refereed Publications

Request Publication

  1. Lubieniecka JM, Graham J, Heffner D, Mottus R, Reid R, Hogge D, Grigliatti TA, Riggs WK. A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor. Front Genet. 2013 Nov 11;4:231. PMID: 24273552
  2. Petersdorf SH, Kopecky KJ, Slovak M, Willman C, Nevill T, Brandwein J, Larson RA, Erba HP, Stiff PJ, Stuart RK, Walter RB, Tallman MS, Stenke L, Appelbaum FR. A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia. Blood. 2013 Jun 13;121(24):4854-60. PMID: 23591789
  3. Stewart AK, Trudel S, Bahlis NJ, White D, Sabry W, Belch A, Reiman T, Roy J, Shustik C, Kovacs MJ, Rubinger M, Cantin G, Song K, Tompkins KA, Marcellus DC, Lacy MQ, Sussman J, Reece D, Brundage M, Harnett EL, Shepherd L, Chapman JA, Meyer RM. A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial. Blood. 2013 Feb 28;121(9):1517-23. PMID: 23297129
  4. Allan D, Petraszko T, Elmoazzen H, Smith S. A review of factors influencing the banking of collected umbilical cord blood units. Stem Cells Int. 2013;2013:463031. PMID: 23533442
  5. Dalal B, Al Mugairi A, Pi S, Khare NS, Pal J, Bryant A, Vakil A, Lau S, Abou Mourad Y. Aberrant Expression of CD13 Identifies a Subgroup of Standard-risk Adult Acute Lymphoblastic Leukemia with Inferior Survival. Clinical Lymphoma, Myeloma & Leukemia
  6. Rosen DB, Harrington KH, Cordeiro JA, Leung LY, Putta S, Lacayo N, Laszlo GS, Gudgeon CJ, Hogge DE, Hawtin RE, Cesano A, Walter RB. AKT signaling as a novel factor associated with in vitro resistance of human AML to gemtuzumab ozogamicin. PLoS One. 2013;8(1):e53518. PMID: 23320091
  7. Ho S, Gue D, McIntosh K, Bucevska M, Yang M, Jackson SC. An objective method for assessing adherence to prophylaxis in adults with severe hemophilia. Haemophilia 2013 DOI: 10.1111/hae.12235 PMID: 23919911
  8. Villa D, Crump M, Panzarella T, Savage KJ, Toze CL, Stewart DA, MacDonald DA, Buckstein R, Lee C, Alzahrani M, Rubinger M, Foley R, Xenocostas A, Sabloff M, Muccilli A, Chua N, Couture F, Larouche JF, Cohen S, Connors JM, Ambler K, Al-Tourah A, Ramadan KM, Kuruvilla J. Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group. J Clin Oncol. 2013 Mar 20;31(9):1164-71. PMID: 23401459
  9. Swanson L, Robertson G, Mungall KL, Butterfield YS, Chiu R, Corbett RD, Docking TR, Hogge D, Jackman SD, Moore RA, Mungall AJ, Nip KM, Parker JD, Qian JQ, Raymond A, Sung S, Tam A, Thiessen N, Varhol R, Wang S, Yorukoglu D, Zhao Y, Hoodless PA, Sahinalp SC, Karsan A, Birol I. Barnacle: detecting and characterizing tandem duplications and fusions in transcriptome assemblies. BMC Genomics. 2013 Aug 14;14:550. PMID: 23941359
  10. Lee AY, Bauersachs R, Janas MS, Jarner MF, Kamphuisen PW, Meyer G, Khorana AA. CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients. BMC Cancer. 2013 Jun 13;13(1):284. PMID: 23764005
  11. Go to top

  12. Farah M, Levin A, Kiaii M, Vickars L, Werb R. Combination hemodialysis and centrifugal therapeutic plasma exchange: 18 years of Canadian experience. Hemodial Int. 2013 Apr;17(2):256-65. PMID: 22928813
  13. Xing Y, Hogge DE. Combined inhibition of the phosphoinosityl-3-kinase (PI3Kinase) P110δ subunit and mitogen-extracellular activated protein kinase (MEKinase) shows synergistic cytotoxicity against human acute myeloid leukemia progenitors. Leuk Res. 2013 Jun;37(6):697-704. PMID: 23522913
  14. Venner CP, Woltosz JW, Nevill TJ, Deeg HJ, Caceres G, Platzbecker U, Scott BL, Sokol L, Sung S, List AF, Karsan A. Correlation of clinical response and response duration with miR-145 induction by lenalidomide in CD34(+) cells from patients with del(5q) myelodysplastic syndrome. Haematologica. 2013 Mar;98(3):409-13. PMID: 22929976
  15. Imran Ul-Haq M, Hamilton JL, Lai BF, Shenoi RA, Horte S, Constantinescu I, Leitch HA, Kizhakkedathu JN. Design of long circulating nontoxic dendritic polymers for the removal of iron in vivo. ACS Nano. 2013 Dec 23;7(12):10704-16. PMID: 24256569
  16. Gerrie AS, Mikhael JR, Cheng L, Jiang H, Kukreti V, Panzarella T, Reece D, Stewart KA, Trieu Y, Trudel S, Chen CI. D(T)PACE as salvage therapy for aggressive or refractory multiple myeloma. Br J Haematol. 2013 Jun;161(6):802-10. PMID: 23594335
  17. Reece D, Song K, LeBlanc R, Mezzi K, Olujohungbe A, White D, Zaman F, Belch A. Efficacy and safety of busulfan-based conditioning regimens for multiple myeloma. Oncologist. 2013;18(5):611-8. PMID: 2362898
  18. Couban S, Savoie L, Abou Mourad Y, Leber B, Minden M, Turner R, Palada V, Shehata N, Christofides A, Lachane S. Evidence-based guidelines for the use of TKI in Adults with Philadelphia Chromosome Positive or BCR-ABL Positive ALL: a Canadian Consensus. Current Oncology
  19. Wong WM, Sigvardsson M, Åstrand-Grundström I, Hogge D, Larsson J, Qian H, Ekblom M. Expression of integrin α2 receptor in human cord blood CD34+CD38-CD90+ stem cells engrafting long-term in NOD/SCID-IL2Rγ(c) null mice. Stem Cells. 2013 Feb;31(2):360-71. PMID: 23165626
  20. Sloma I, Beer PA, Saw KM, Chan M, Leung D, Raghuram K, Brimacombe C, Johnston B, Lambie K, Forrest D, Jiang X, Eaves CJ. Genotypic and functional diversity of phenotypically defined primitive hematopoietic cells in patients with chronic myeloid leukemia. Exp Hematol. 2013 Oct;41(10):837-47. PMID: 23851302
  21. Cheung C, Owen D, Brar H, Sweet DD, Yoshida E, Dalal BI, Chen LY. Hemophagocytic Lymphohistiocytosis in Adults: Two Instructive Cases. UBC Medical Journal 2013: 4(2)
  22. Go to top

  23. Smith TW, Lee AYY. Heritable thrombophilia testing in British Columbia: A report on practice pattern and prevalence. BCMJ 2013;55:78-82. SA.
  24. Wong PC, Fung AT, Gerrie AS, Moloney G, Maberley D, Rossman D, White V, Collins D, Coupland R, Chen LY. IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy. Eur J Haematol. 2013 Mar;90(3):250-6. PMID: 23278107
  25. Lee A, Sieling PA, Lee DJ. Immune correlates of melanoma survival in adoptive cell therapy. Oncoimmunology. 2013 Feb 1;2(2):e22889. PMID: 23525606
  26. Deangelo DJ, Chen L, Guerin A, Styles A, Giguere-Duval P, Wu EQ. Impact of Timely Switching From Imatinib to a Second-Generation Tyrosine Kinase Inhibitor After 12-Month Complete Cytogenetic Response Failure: A Chart Review Analysis. Clin Lymphoma Myeloma Leuk. 2013 Dec 17. PMID: 24393622
  27. Valencia-Serna J, Gul-Uludag H, Mahdipoor P, Jiang X and Uludag H. Investigating siRNA delivery to chronic myeloid leukemia K562 cells with lipophilic polymers for therapeutic BCR-ABL down-regulation. J Controlled Release
  28. Smith NC, Bartholomew C, Jackson S. Issues in the ageing individual with haemophilia and other inherited bleeding disorders: understanding and responding to the patients’ perspective. Haemophilia 2013 DOI: 10.1111/hae.12278 PMID: 24118548
  29. Zeng F, Chen MJ, Gong ZJ, Baldwin D, Qian H, Yan JB, Wang J, Chen X, Xiao YP, Chalandon Y, Ringrose A, Ren ZR, Eaves A, Eaves C, Huang SZ & Jiang X. Long-term deregulated human hematopoiesis in goats transplanted in utero with BCR-ABL-transduced Lin-CD34+ cord blood cells. Cell Research 23,859-62, 2013.
  30. Carrier M, Khorana AA, Zwicker JI, Noble S, Lee AYY, on behalf of the Subcommittee on Haemostasis and Malignancy for the SSC of the ISTH. Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH. J Thromb Haemost 2013 (Oct);11:1760-5. PMID: 23809334
  31. Abou Mourad YR, Bhargava R, Bruyère H, Gillian T, Barnett MJ, Forrest DL, Nevill TJ, Toze CL, Nantel SH, Shepherd JD. Normal karyotype CALLA-positive adult pre-B ALL: dismal outcome with chemotherapy for patients with loss/gain of ABL1 and/or BCR FISH signals. Clin Lymphoma Myeloma Leuk. 2013 Jun;13(3):281-6. PMID: 23098889
  32. Minden MD, Hogge DE, Weir SJ, Kasper J, Webster DA, Patton L, Jitkova Y, Hurren R, Gronda M, Goard CA, Rajewski LG, Haslam JL, Heppert KE, Schorno K, Chang H, Brandwein JM, Gupta V, Schuh AC, Trudel S, Yee KW, Reed GA, Schimmer AD. Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies. Am J Hematol. 2013 Nov 25. PMID: 24273151
  33. Go to top

  34. San-Miguel JF, Richardson PG, Günther A, Sezer O, Siegel D, Bladé J, LeBlanc R, Sutherland H, Sopala M, Mishra KK, Mu S, Bourquelot PM, Victoria Mateos M, Anderson KC. Phase Ib study of panobinostat and bortezomib in relapsed or relapsed and refractory multiple myeloma. J Clin Oncol. 2013 Oct 10;31(29):3696-703. PMID: 24019544
  35. Miguel JS, Weisel K, Moreau P, Lacy M, Song K, Delforge M, Karlin L, Goldschmidt H, Banos A, Oriol A, Alegre A, Chen C, Cavo M, Garderet L, Ivanova V, Martinez-Lopez J, Belch A, Palumbo A, Schey S, Sonneveld P, Yu X, Sternas L, Jacques C, Zaki M, Dimopoulos M. Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial. Lancet Oncol. 2013 Oct;14(11):1055-66. PMID: 24007748
  36. Mak V, Ip D, Mang O, Dalal C, Huang S, Gerrie A, Gillan T, Ramadan KM, Toze C, Au WY. Preservation of lower incidence of chronic lymphocytic leukemia in Chinese residents in British Columbia: a 26-year survey from 1983 to 2008. Leuk Lymphoma. 2013 Sep 12. PMID:23909397
  37. Palfreyman E, Song K, Nantel S. Pseudo-autologous hematopoietic SCT as treatment for a patient with multiple myeloma who relapsed following an allogeneic hematopoietic SCT. Bone Marrow Transplant. 2013 Aug;48(8):1138. PMID: 23419431
  38. Smith TW, Pi D, Hudoba M, Lee AY. Reducing inpatient heritable thrombophilia testing using a clinical decision-making tool. J Clin Pathol. 2013 Oct 29. PMID: 24170209
  39. Chan WS, Spencer FA, Lee AY, Chunilal S, Douketis JD, Rodger M, Ginsberg JS. Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging. CMAJ. 2013 Mar 5;185(4):E194-200. doi: 10.1503/cmaj.120895. Epub 2013 Jan 14. PMID: 23318405
  40. Linkins LA, Bates SM, Lang E, Kahn SR, Douketis JD, Julian J, Parpia S, Gross P, Weitz JI, Spencer FA, Lee AY, O’Donnell MJ, Crowther MA, Chan HH, Lim W, Schulman S, Ginsberg JS, Kearon C. Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial. Ann Intern Med. 2013 Jan 15;158(2):93-100. PMID: 23318311
  41. Lubieniecka JM, Liu J, Graham J, Heffner D, Reid R, Hogge D, Grigliatti TA, Riggs WK. Single-nucleotide polymorphisms in reductase genes are not associated with response to daunorubicin-based remission induction. Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1918-20. PMID: 23880735
  42. Gang EJ, Hsieh Y-T, Pham J, Zhao Y, Nguyen C, Huantes S, Park E, Naing K,1 Klemm L, Swaminathan S, Conway EM, Pelus L, Crispino J, Mullighan C, MacMillan M, Müschen M, Kahn M, Kim Y-M. Small molecule inhibition of CBP/catenin interactions eliminates drug resistant clones in acute lymphoblastic leukemia. Oncogene 2013. In Press. PMID:23728349
  43. Sharp ME, Laule C, Nantel S, Mädler B, Aul RB, Yip S, Sirrs S. Stem cell transplantation for adult-onset krabbe disease: report of a case. JIMD Rep. 2013;10:57-9. PMID: 23430802
  44. Go to top

  45. Chen M, Gallipoli P, DeGeer D, Sloma I, Forrest DL, Chan M, Lai D, Jorgensen H, Ringrose A, Wang HM, Lambie K, Nakamoto H, Saw KM, Turhan A, Arlinghaus R, Paul J, Stobo J, Barnett MJ, Eaves A, Eaves CJ, Holyoake TL, Jiang X. Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex. J Natl Cancer Inst. 2013 Mar 20;105(6):405-23. PMID: 23446755
  46. Leitch HA, Buckstein R, Shamy A, Storring JM. The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: a clinical practice guideline. Crit Rev Oncol Hematol. 2013 Feb;85(2):162-92. PMID: 22901762
  47. Lieberman L, Petraszko T, Yi QL, Hannach B, Skeate R. Transfusion-related lung injury in children: a case series and review of the literature. Transfusion. 2013 Jun 13. PMID: 23763359
  48. Lee AY, Peterson EA. Treatment of cancer-associated thrombosis. Blood. 2013 Oct 3;122(14):2310-7. PMID: 23843493
  49. Brandwein JM, Geddes M, Kassis J, Kew AK, Leber B, Nevill T, Sabloff M, Sandhu I, Schuh AC, Storring JM, Ashkenas J. Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensus. Am J Blood Res. 2013 May 5;3(2):141-64. Print 2013. PMID: 23675565
  50. Jakubowiak AJ, Siegel DS, Martin T, Wang M, Vij R, Lonial S, Trudel S, Kukreti V, Bahlis N, Alsina M, Chanan-Khan A, Baudi F, Reu FJ, Somlo G, Zonder J, Song K, Stewart AK, Stadtmauer E, Harrison BL, Wong AF, Orlowski RZ Jagannath S. Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study. Leukemia (2013) 27, 2351–2356; doi:10.1038/leu.2013.152
  51. Klaassen RJ, Barrowman N, Merelles-Pulcini M, Vichinsky EP, Sweeters N, Kirby-Allen M, Neufeld EJ, Kwiatkowski JL, Wu J, Vickars L, Blanchette VS, Forgie M, Yamashita R, Wong-Rieger D, Young NL. Validation and reliability of a disease-specific quality of life measure (the TranQol) in adults and children with thalassaemia major. Br J Haematol. 2013 Nov 3. PMID: 24180641
  52. Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Prestrud AA, Falanga A; American Society of Clinical Oncology Clinical Practice. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013 Jun 10;31(17):2189-204. PMID: 2366922

Go to top